JAZZ Venture Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Swing TherapeuticsinAug 2019Acquired
Digital therapeutics developer behind Stanza, an FDA-authorized smartphone behavioral therapy for fibromyalgia symptoms.
BiotechHealthtechSan Francisco, US
Michael Rosenbluth(Executive Officer, Director)
BoardCorey McCann(Director)
Board seatAndrew FirlikZack Lynch· per SEC Form D
Co-investorsKicker VenturesJAZZ Human PerformanceMetrodora Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.